IGLON5 and central nervous system disorder: Sleep disorders have recently been described in association with a number of autoantibody-associated CNS disorders, including anti-IgLON5 [32, 33], anti-DPPX [34–36], anti-CASPR2 and anti-NMDAR encephalitis [37].